Show simple item record

Radotinib in the treatment of chronic phase chronic myeloid leukemia patients

dc.contributor.authorEskazan, AHMET EMRE
dc.contributor.authorSoysal, Teoman
dc.date.accessioned2021-03-03T20:50:26Z
dc.date.available2021-03-03T20:50:26Z
dc.date.issued2015
dc.identifier.citationEskazan A. E. , Soysal T., "Radotinib in the treatment of chronic phase chronic myeloid leukemia patients", HAEMATOLOGICA, cilt.100, sa.1, 2015
dc.identifier.issn0390-6078
dc.identifier.othervv_1032021
dc.identifier.otherav_5c0ef76a-4a02-412a-b5ad-605827b5c776
dc.identifier.urihttp://hdl.handle.net/20.500.12627/64564
dc.identifier.urihttps://doi.org/10.3324/haematol.2014.117846
dc.language.isoeng
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleRadotinib in the treatment of chronic phase chronic myeloid leukemia patients
dc.typeMakale
dc.relation.journalHAEMATOLOGICA
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume100
dc.identifier.issue1
dc.contributor.firstauthorID100036


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record